Abstract
The Hispanic or Latino population is the largest minority group in the United States, currently representing 13.7% of the total U.S. population. Hispanics or Latinos usually suffer from higher rates of type 2 diabetes, obesity, metabolic syndrome, and their multiple vascular complications. Inadequate nutrition and reduced physical activity in the setting of an increased genetic predisposition to type 2 diabetes have contributed to the inexorable rise in metabolic abnormalities in Hispanics in the United States, which now affect many children and adolescents. It is evident that multiple medical, cultural, and socioeconomic factors influence the development of diabetes, its course, and its consequences. Our health care system is barely prepared to face the challenge of managing diabetes in this high-risk group. Culturally oriented clinical care, education, outreach and research programs are needed to better identify the challenges to create opportunities to improve the lives of Hispanics or Latinos with diabetes or at risk for the disease.
Similar content being viewed by others
References and Recommended Reading
Hispanic and Asian Americans Increasing Faster Than Overall Population [press release]. US Census Bureau. Available at http://www.census.gov/Press-Release/www/releases/archives/race/001839.html. Accessed June 14, 2004.
Ramirez RR, De la Cruz PG: The Hispanic Population in the United States: March 2002. Current Population Reports, P20-545. Washington, DC: U.S. Census Bureau; Available at http:// www.census.gov/prod/2003pubs/p20-545.pdf.2002.
Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey (NHANES), 1988–1994. Diabetes Care 1998, 21:518–524.
Centers for Disease Control and Prevention: Prevalence of diabetes among Hispanics-selected areas, 1998–2002. MMWR Morb Mortal Wkly Rep 2004, 53:941–944.
Narayan KMV, Boyle JP, Thompson TJ, et al.: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884–1890.
Goran MI, Ball GD, Cruz ML: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003, 88:1417–1427. An updated review of the impact of obesity in the pediatric population and how it relates to the increasing number of children with type 2 diabetes.
Flegal KM, Ezzati TM, Harris MI, et al.: Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Examination Survey (HHANES), 1982–1984. Diabetes Care 1991, 14(suppl 3):628–638.
Swenson CJ, Trepka MJ, Rewers MJ, et al.: Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol 2002, 156:919–928.
Hanis CL, Chu HH, Lawson K, et al.: Mortality of Mexican Americans with NIDDM. Retinopathy and other predictors in Starr County, Texas. Diabetes Care 1993, 16:82–89.
Gilliland FD, Owen C, Gilliland SS, et al.: Temporal trends in diabetes mortality among American Indians and Hispanics in New Mexico: birth cohort and period effects. Am J Epidemiol 1997, 145:422–431.
Hunt KJ, Williams K, Resendez RG, et al.: All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox." Diabetes Care 2002, 25:1557–1563.
Neel JV: Diabetes mellitus: a thrifty genotype rendered detrimental by progress? Am J Hum Genet 1962, 14:353–362.
Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al.: Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 2001, 24:2059–2064.
Langefeld CD, Wagenknecht LE, Rotter JI, et al.: Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families. The Insulin Resistance Atherosclerosis Study Family Study. Diabetes 2004, 53:1170–1174.
Ferranini E, Gastaldelli A, Matsuda M, et al.: Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. J Clin Endocrinol Metab 2003, 88:3251–3257. An updated review of the pathophysiology of type 2 diabetes, particularly in regard to the connection between ethnicity and insulin resistance.
Haffner SM, D'Agostino R, Saad MF, et al.: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with Non-Hispanic Whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996, 45:742–748.
Goran MI, Bergman RN, Cruz ML, Watanabe RM: Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 2002, 25:2184–2190.
Chiu KC, Cohan P, Lee NP, Chuang LM: Insulin sensitivity differs among ethnic groups with a compensatory response in beta cell function. Diabetes Care 2000, 23:1353–1359.
Haffner SM, Mietinen H, Gaskill SP, et al.: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of non-insulin dependent diabetes mellitus in Mexican Americans. Diabetes 1995, 44:1386–1391.
Cossrow N, Falkner B: Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004, 89:2590–2594.
Flegal KM, Carroll MD, Kuczmarski RJ, et al.: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998, 22:39–47.
Ogden CL, Flegal KM, Carroll MD, et al.: Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 2002, 288:1728–1732.
Caballero AE: Obesity, insulin resistance and endothelial dysfunction. The road to type 2 diabetes and cardiovascular disease. Obes Res 2003, 11:1278–1289.
Goel MS, McCarthy EP, Phillips RS, Wee CC: Obesity among US immigrant subgroups by duration of residence. JAMA 2004, 292:2860–2867.
Burke JP, Williams K, Haffner SM, et al.: Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001, 24:1573–1578.
US Interagency Committee on Nutrition Monitoring. U.S. Public Health Service and U.S. Department of Agriculture: Nutrition Monitoring in the United States: the Directory of Federal Nutrition Monitoring Activities. DHHS Publication no. (PHS) 89-1255. Hyattsville, MD: Department of Health and Human Service; 1989.
Hollingsworth DR, Vaucher Y, Yamamoto TR: Diabetes in pregnancy in Mexican Americans. Diabetes Care 1991, 14:695–705.
Peters RK, Kjos SL, Xiang A, et al.: Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes. Lancet 1996, 347:227–230.
Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.
Park YW, Zhu S, Palaniappan L, et al.: The metabolic syndrome: prevalence and associated risk factors findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003, 163:427–436.
Aguilar-Salinas CA, Olaiz G, Valles V, et al.: High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001, 42:1298–1307.
Caballero AE: Diabetes in minority populations. In Joslin's Diabetes Mellitus, edn 14. Edited by Kahn RC, et al. Philadelphia: Lippincott Williams & Wilkins; 2005:505–524.
Harris MI, Eastman RC, Cowie CC, et al.: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999, 22:403–408.
Pugh JA, Tuley MR, Hazuda HP, et al.: The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complications 1992, 6:236–241.
Haffner SM, Fong D, Stern MP, et al.: Diabetic retinopathy in Mexican Americans and non-Hispanic Whites. Diabetes 1988, 37:878–884.
Harris MI, Klein R, Cowie CC, et al.: Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 1998, 21:1230–1235.
Hamman RF, Franklin GA, Mayer E, et al.: Microvascular complications of NIDDM in Hispanics and non-Hispanics Whites. San Luis Valley Diabetes Study. Diabetes Care 1991, 14:655–664.
Haffner SM, Mitchell BD, Pugh JA, et al.: Proteinuria in Mexican Americans and non Hispanic whites with NIDDM. Diabetes Care 1989, 12:530–536.
Harris MI: Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care 2001, 24:454–459.
Pugh JA, Tuley MR, Basu S: Survival among Mexican-Americans, non-Hispanic Whites and African-Americans with endstage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis 1994, 23:803–807.
Murthy BV, Molony DA, Stack AG: Survival advantage of Hispanic patients initiating dialysis in the Unites States is modified by race. J Am Soc Nephrol 2005, 16:782–790.
Sands ML, Shetterly SM, Franklin GM, Hamman RF: Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1997, 20:322–329.
Harris MI, Cowie CC, Eastman RC: Symptoms of sensory neuropathy in adults with diabetes in the U.S. population. Diabetes Care 1993, 16:1446–1452.
Lavery LA, van Houtum WH, Ashry HR, et al.: Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med J 1999, 92:593–599.
Haffner SM, Mitchell BD, Stern MP, et al.: Macrovascular complications in Mexican Americans with type II diabetes. Diabetes Care 1991, 14:665–671.
Caballero AE, Habershaw GM, Pinzur MS: Preventing amputations in patients with diabetes. Caring for diverse populations. Patient Care 2000, 05:113–133.
Ford ES, Giles WH, Croft JB: Prevalence of nonfatal coronary heart disease among American adults. Am Heart J 2000, 139:371–377.
Stern M, Bradshaw B, Eifler C, et al.: Secular decline in death rates due to ischemic heart disease in Mexican Americans and non-Hispanic Whites in Texas, 1970–1980. Circulation 1987, 76:1245–1250.
Lerman-Garber I, Villa AR, Caballero AE: Diabetes and Cardiovascular Disease. Is there a true Hispanic Paradox? Rev Invest Clinic 2004, 56:282–296. Available at http:// www.imbiomed.com.mx.
D'Agostino RB, Burke G, O'Leary D, et al.: Ethnic differences in carotid wall thickness. The Insulin Resistance and Atherosclerosis Study. Stroke 1996, 27:1744–1749.
Sacco RL, RobertsKBoden, et al.: Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. Stroke 1997, 28:929–935.
Flores G: Culture and the patient-physician relationship: achieving cultural competency in health care. J Pediatr 2000, 136:14–23.
Kimanyika S: Special issues regarding obesity in minority populations. Ann Intern Med 1993, 119:650–654.
Ho RC, Davy KP, Hickey MS, et al.: Behavioral, metabolic and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Physiol Endocrinol Metab 2002, 283:E799-E808.
Haffner SM, Knapp JA, Hazuda HP, et al.: Dietary intakes of macronutrients among Mexican Americans and Anglo Americans. The San Antonio Heart Study. Am J Clin Nutr 1985, 42:1266–1275.
Frati AC, Gordillo BE, Altamriano P, et al.: Acute hypoglycemic effect of Opuntia streptacantha Lemaire in NIDDM [letter]. Diabetes Care 1990, 13:455–456.
Crespo CJ, Keteyian SJ, Heath GW, et al.: Leisure-time physical activity among U.S. adults. Arch Intern Med 1996, 156:93–98.
Monterrosa AE, Haffner SM, Stern MP, et al.: Sex difference in lifestyle factors predictive of diabetes in Mexican Americans. Diabetes Care 1995, 18:448–456.
Stern MP, Knapp JA, Hazuda HP, et al.: Genetic and environmental determinants of type II diabetes in Mexican Americans. Is there a descending limb to the modernization/ diabetes relationship? Diabetes Care 1991, 14:649–654.
Hazuda HP, Haffner SM, Stern MP, et al.: Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 1988, 128:1289–1301.
Hazuda HP, Monterrosa A: Social class predicts 8-year incidence of diabetes in Mexican Americans and non-Hispanic whites. Diabetes 1992, 41:179A.
Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003, 26:2822–2828.
Lerman I, Lozano L, Villa AR, et al.: Psychosocial factors associated with poor diabetes self-care management in a specialized Center in Mexico City. Biomed Pharmacother 2004, 58:566–570.
Solis JM, Marks G, Garcia M, Shelton D: Acculturation, access to care and use of preventive services by Hispanics: findings from HHANES 1982–1984. Am J Public Health 1990, 80(suppl):11–19.
Fernandez A, Schillinger D, Grumback K, et al.: Physician language ability and cultural competence. An exploratory study of communication with Spanish-speaking patients. J Gen Intern Med 2004, 19:167–174. An interesting article in regard to the growing area of cultural competence and its influence on physician-patient interaction.
Brown SA, Garcia AA, Kouzekanani K, Hanis CL: Culturally competent diabetes self-management education for Mexican Americans. The Starr County Border Health Initiative. Diabetes Care 2002, 25:259–268.
Caballero AE, Ward K, Hill J, Abeln C: The Latino Diabetes Initiative: a comprehensive clinical care, education and research program to improve the lives of Latinos with diabetes and at risk for the disease. Diabetes 2004, 53(suppl 2):A552-A553.
Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.
Caballero AE, Delgado A, Naranjo A, et al.: Metformin improves markers of endothelial activiation but not markers of inflammation in subjects with impaired glucose tolerance. J Clin Endocrinol Metab 2004, 89:3943–3948.
Buchanan TA, Xiang AH, Peters RK, et al.: Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002, 51:2796–2803.
Caballero AE: Endothelial dysfunction, inflammation and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep 2004, 4:237–246. An updated review of the metabolic and vascular abnormalities in individuals at risk for type 2 diabetes.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caballero, A.E. Diabetes in the hispanic or latino population: Genes, environment, culture, and more. Curr Diab Rep 5, 217–225 (2005). https://doi.org/10.1007/s11892-005-0012-5
Issue Date:
DOI: https://doi.org/10.1007/s11892-005-0012-5